This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
VAKITI A., MEWAWALLA P. Acute Myeloid Leukemia. StatPearls [Internet]. 2021 Aug 17 [cited 2022 Jul 12]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK507875/Search in Google Scholar
DӦHNER H., WEI A.H., APPELBAUM F.R., CRADDOCK C., DINARDO C.D., DOMBRET H., et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–77.Search in Google Scholar
KHOURY J.D., SOLARY E., ABLA O., AKKARI Y., ALAGGIO R., APPERLEY J.F., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703-1719.Search in Google Scholar
RACK K.A., VAN DEN BERG E., HAFERLACH C., BEVERLOO H.B., COSTA D., ESPINET B., et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia. 2020;34(8):2262.Search in Google Scholar
YAHYA D., HACHMERIYAN M., MICHEVA I., CHERVENKOV T. Acute myelogenous leukemia – current recommendations and approaches in molecular-genetic assessment. Romanian Journal of Internal Medicine. 2022;60(2):103–14.Search in Google Scholar
ALONSO C.M., LLOP M., SARGAS C., PEDROLA L., PANADERO J., HERVÁS D., et al. Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics. Journal of Molecular Diagnostics. 2019;21(2):228–40.Search in Google Scholar
IBÁÑEZ M., SUCH E., ONECHA E., GOMEZ-SEGUI I., LIQUORI A., SELLES J., et al. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype. Scientific Reports. 2020;10(1):1–12.Search in Google Scholar
BERRY N.K., SCOTT R.J., ROWLINGS P., ENJETI A.K. Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies. Crit Rev Oncol Hematol. 2019;142:58–67.Search in Google Scholar
LEISCH M., JANSKO B., ZABORSKY N., GREIL R., PLEYER L. Next Generation Sequencing in AML–On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation? Cancers (Basel). 2019;11(2):252.Search in Google Scholar
HӦMIG-HӦLZEL C., SAVOLA S. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol. 2012;21(4):189–206.Search in Google Scholar
PAYNE A.B., BEAN C.J., HOOPER W.C., MILLER C.H. Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening. J Thromb Haemost. 2012;10(9):1951–4.Search in Google Scholar
ALPÁR D., DE JONG D., SAVOLA S., YIGITTOP H.A., KAJTÁR B., KERESKAI L., et al. MLPA is a powerful tool for detecting lymphoblastic transformation in chronic myeloid leukemia and revealing the clonal origin of relapse in pediatric acute lymphoblastic leukemia. Cancer Genet. 2012;205(9):465–9.Search in Google Scholar
KOSZTOLANYI S., KISS R., ATANESYAN L., GÁNGO A., de Groot K, Steenkamer M, et al. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma. The Journal of Molecular Diagnostics. 2018;20(6):777–88.Search in Google Scholar
AHN J.W., MACKIE O.C., WELCH A., THOMAS H., MADULA R., HILLS A., et al. Detection of subtelomere imbalance using MLPA: Validation, development of an analysis protocol, and application in a diagnostic centre. BMC Med Genet. 2007;8(1):1–13.Search in Google Scholar
STUPPIA L., ANTONUCCI I., PALKA G., GATTA V. Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases. Int J Mol Sci. 2012;13(3):3245–76.Search in Google Scholar
BALGOBIND B.V., HOLLINK I.H.I.M., REINHARDT D., VAN WERING E.R., DE GRAAF S.S.N., BARUCHEL A., et al. Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. Eur J Cancer. 2010 Jul;46(10):1892–9.Search in Google Scholar
YU C.H., LIN T.K., JOU S.T., LIN C.Y., LIN K.H., LU M.Y., et al. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. Scientific Reports. 2020;10(1):1–11.Search in Google Scholar
DONAHUE A.C., ABDOOL A.K., GAUR R., WOHLGEMUTH J.G., YEH C.H. Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia. Leuk Res. 2011;35(11):1477–83.Search in Google Scholar
BANESKU C., TRIPON F., TRIFA A.P., CRAUCIUC A.G., BOGLIS A., LAZAR E., et al. Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Pol Arch Intern Med. 2019; 129(12):898-906Search in Google Scholar
SHIMONY S., STAHL M., STONE R.M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502–26.Search in Google Scholar
TRIPON F., CRAUCIUC A.G., MOLDOVAN V.G., BOGLIS A., BENEDEK I., LAZAR E., et al. Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study. Rev Rom Med Lab. 2019;27(3):245–54.Search in Google Scholar
BANESKU C., TRIPON F., TRIFA A.P., CRAUCIUC A.G., BOGLIS A., LAZAR E., et al. Presence of copy number aberrations and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Authors’ reply. Pol Arch Intern Med. 2020;130(4):347–8.Search in Google Scholar
